Evercore ISI on Humana (HUM): CenterWell partnership with Cuban Cost Plus offers 'some modest benefit'
Tweet Send to a Friend
Evercore ISI analyst Elizabeth Anderson reiterated an In Line rating and $195.00 price target on Humana (NYSE: HUM)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
